Meghraj Vivekanand Suryawanshi | Pharmaceutics | Innovative Research Award

Published-on by Indian Scientist

Innovative Research Award

Meghraj Vivekanand Suryawanshi
Affiliation Savitribai Phule Pune University
Country India
Scopus ID 58037948200
Documents 48
Citations 104
h-index 5
Subject Area Pharmaceutics
Event Indian Scientist Awards
ORCID 0000-0003-3958-2813

Meghraj Vivekanand Suryawanshi

Savitribai Phule Pune University, India

Meghraj Vivekanand Suryawanshi has contributed to the field of Pharmaceutics through research activities reflected in indexed publications, citations, and measurable scholarly impact. His academic profile demonstrates sustained engagement in pharmaceutical sciences and related research domains, supporting scientific knowledge dissemination and interdisciplinary collaboration.[1][2]

Abstract

This article presents an academic overview of Meghraj Vivekanand Suryawanshi and his scholarly contributions within the field of Pharmaceutics. The profile highlights publication activity, citation performance, research engagement, and academic impact indicators documented through internationally recognized indexing platforms. The assessment considers research productivity, contribution to pharmaceutical sciences, and relevance to innovation-oriented scientific recognition programs.[1]

Keywords

Pharmaceutics, Drug Delivery Systems, Pharmaceutical Research, Scientific Innovation, Research Impact, Scholarly Publications, Citation Analysis, Academic Recognition, Pharmaceutical Sciences, Innovative Research Award.

Introduction

Research in pharmaceutics plays a fundamental role in improving therapeutic outcomes, formulation technologies, drug delivery mechanisms, and pharmaceutical manufacturing processes. Academic researchers contribute to the advancement of healthcare through experimental investigations, translational research, and dissemination of scientific findings. Meghraj Vivekanand Suryawanshi’s scholarly profile reflects active participation in these efforts through publication and citation records indexed in major academic databases.[1]

Research Profile

Meghraj Vivekanand Suryawanshi is affiliated with Savitribai Phule Pune University, a recognized institution engaged in higher education and scientific research. His documented scholarly profile includes research publications indexed in Scopus, demonstrating contributions to pharmaceutical sciences and related disciplines.[1]

  • Institutional Affiliation: Savitribai Phule Pune University.
  • Country of Research Activity: India.
  • Scopus Indexed Documents: 48.
  • Citation Count: 104.
  • h-index: 5.
  • Primary Subject Area: Pharmaceutics.

Research Contributions

The research contributions associated with this profile encompass pharmaceutical formulation studies, drug delivery approaches, evaluation methodologies, and related pharmaceutical investigations. Such work supports the broader objective of improving therapeutic effectiveness and scientific understanding within the pharmaceutical sector.[3]

  • Development and evaluation of pharmaceutical formulations.
  • Investigation of drug delivery technologies.
  • Research supporting pharmaceutical quality and efficacy assessment.
  • Contribution to peer-reviewed scientific literature.
  • Participation in collaborative and interdisciplinary research activities.

Publications

Publication activity serves as an important indicator of academic productivity. The available bibliometric profile demonstrates a record of peer-reviewed outputs that contribute to knowledge generation in pharmaceutical sciences and allied research areas.[1]

  1. Research articles indexed in international scientific databases.
  2. Studies related to pharmaceutical formulation and evaluation.
  3. Scientific communications supporting evidence-based pharmaceutical development.
  4. Collaborative publications contributing to interdisciplinary knowledge exchange.

Research Impact

Research impact may be evaluated through bibliometric indicators including publication volume, citation performance, and h-index metrics. With 48 indexed documents, 104 citations, and an h-index of 5, the profile demonstrates measurable scholarly visibility within the academic community.[1]

  • Evidence of sustained scholarly publication activity.
  • Research findings referenced by other investigators.
  • Contribution to scientific discourse within pharmaceutics.
  • Academic visibility reflected through citation metrics.

Award Suitability

The Innovative Research Award recognizes researchers whose scholarly activities contribute to scientific advancement and innovation. Based on the documented research profile, publication record, citation indicators, and engagement in pharmaceutical sciences, Meghraj Vivekanand Suryawanshi demonstrates attributes commonly associated with academic recognition programs emphasizing innovation, research productivity, and knowledge dissemination.[1][2]

Conclusion

Meghraj Vivekanand Suryawanshi’s academic profile reflects sustained participation in pharmaceutical research and scholarly publication. Through documented contributions in Pharmaceutics, indexed publications, citation performance, and measurable research indicators, the profile represents ongoing engagement with scientific inquiry and evidence-based knowledge development. These characteristics align with the objectives of professional research recognition initiatives such as the Innovative Research Award.[1]

References

  1. Scopus author details: Meghraj Vivekanand Suryawanshi, Author ID 58037948200. Scopus.https://www.scopus.com/authid/detail.uri?authorId=58037948200
  2. Medicinal and Nutritional Importance of Hypericum perforatum in Human Health.https://link.springer.com/chapter/10.1007/978-981-95-3620-7_13
  3. Neuroprotective efficacy of Nyctanthes arbor-tristis in a rotenone-induced rat model of Parkinson’s disease

    https://www.sciencedirect.com/science/article/abs/pii/S0378874126006781?via%3Dihub

Jon Jyoti Sahariah | Medicinal Chemistry | Research Excellence Award

Published-on by Indian Scientist

Research Excellence Award

Jon Jyoti Sahariah
Dibrugarh University, India

Jon Jyoti Sahariah
Affiliation Dibrugarh University
Country India
Scopus ID 57225212218
Documents 19
Citations 125
h-index 6
Subject Area Medicinal Chemistry
Event Indian Scientist Awards

Jon Jyoti Sahariah is an academic researcher affiliated with Dibrugarh University, India, whose scholarly activities are associated with medicinal chemistry, pharmaceutical sciences, drug delivery systems, and therapeutic development. His published research contributions demonstrate engagement with contemporary challenges in drug discovery, targeted therapeutics, and biomedical innovation. Through peer-reviewed publications, citation impact, and interdisciplinary collaborations, he has contributed to advancing scientific understanding within medicinal chemistry and related biomedical disciplines.[1]

Abstract

This article presents an academic overview of Jon Jyoti Sahariah and his scholarly contributions within medicinal chemistry and pharmaceutical research. The profile summarizes research interests, publication records, citation metrics, scientific influence, and relevance to recognition through the Research Excellence Award. The assessment is based on publicly available scholarly indicators and peer-reviewed academic outputs.[1]

Keywords

Medicinal Chemistry, Drug Discovery, Pharmaceutical Sciences, Targeted Drug Delivery, Cancer Therapeutics, Liposomal Formulations, Biomedical Research, Therapeutic Development, Scientific Publications, Research Excellence.

Introduction

Medicinal chemistry plays a critical role in the development of novel therapeutic agents and advanced healthcare solutions. Researchers working in this field contribute to the identification, optimization, and evaluation of biologically active compounds for the prevention and treatment of diseases. Jon Jyoti Sahariah’s academic activities align with these objectives through investigations focused on pharmaceutical formulations, drug delivery systems, and therapeutic innovations. His work reflects interdisciplinary collaboration across chemistry, pharmacy, and biomedical sciences.[2]

Research Profile

The scholarly profile of Jon Jyoti Sahariah demonstrates sustained participation in scientific research and publication. According to available bibliometric indicators, his research output includes nineteen indexed documents, 125 citations, and an h-index of six. These metrics indicate measurable academic visibility and engagement within the scientific community. His publications encompass medicinal chemistry, drug delivery technologies, cancer therapeutics, and pharmaceutical innovations.[1]

  • Affiliation with Dibrugarh University, India.
  • Research specialization in medicinal chemistry and pharmaceutical sciences.
  • Indexed publications in peer-reviewed journals.
  • Interdisciplinary collaboration involving drug discovery and therapeutic development.

Research Contributions

Jon Jyoti Sahariah has contributed to studies involving natural bioactive compounds, targeted cancer therapies, liposomal drug delivery systems, and pharmaceutical technologies. Several publications examine mechanisms for improving therapeutic efficacy while reducing adverse effects associated with conventional treatments. Research efforts in these domains contribute to ongoing developments in precision medicine and translational pharmaceutical science.[3]

  • Investigation of natural compounds with therapeutic potential.
  • Research on advanced liposomal drug delivery systems.
  • Contributions to targeted cancer therapy methodologies.
  • Participation in multidisciplinary biomedical research projects.

Publications

Selected scholarly works associated with Jon Jyoti Sahariah include publications addressing cancer chemotherapy, liposomal drug delivery, and medicinal chemistry innovations. Representative studies include highly cited articles focusing on natural bioactive compounds and targeted therapeutic approaches.[3]

  1. Cancer Chemotherapy via Natural Bioactive Compounds.
  2. Advancing Liposomal Doxorubicin for Targeted Cancer Therapy.
  3. Research involving pharmaceutical formulation and drug delivery technologies.
  4. Studies related to medicinal chemistry and therapeutic development.

Research Impact

Research impact can be assessed through publication output, citation frequency, collaborative scholarship, and relevance to scientific advancement. The citation record associated with Jon Jyoti Sahariah indicates that his work has been referenced by researchers in related fields, reflecting scholarly engagement and knowledge dissemination. Contributions to pharmaceutical sciences and medicinal chemistry support ongoing scientific dialogue regarding improved therapeutic interventions.[1]

Award Suitability

The Research Excellence Award recognizes researchers demonstrating meaningful scholarly contributions, scientific productivity, and academic influence. Based on available publication records, citation metrics, and participation in medicinal chemistry research, Jon Jyoti Sahariah exhibits characteristics consistent with the objectives of academic recognition programs. His work contributes to knowledge advancement in pharmaceutical and biomedical sciences while supporting innovation in therapeutic research.[1][4]

Conclusion

Jon Jyoti Sahariah has established a scholarly profile characterized by contributions to medicinal chemistry, drug delivery systems, and pharmaceutical sciences. Through peer-reviewed publications, citation impact, and collaborative scientific efforts, he has participated in research addressing significant healthcare and therapeutic challenges. His academic record supports consideration for professional recognition through the Research Excellence Award and reflects ongoing engagement with scientific advancement.[1]

References

  1. Scopus author details: Jon Jyoti Sahariah, Author ID 57225212218. Scopus. https://www.scopus.com/authid/detail.uri?authorId=57225212218
  2. Cancer chemotherapy via natural bioactive compounds. https://www.benthamdirect.com/content/journals/cddt/10.2174/1570163819666220331095744
  3. From bench to bedside: Advancing liposomal doxorubicin for targeted cancer therapy. https://www.sciencedirect.com/science/article/pii/S2666845925000601
  4. Revolutionizing patient care: 3D printing for customized medical devices and therapeutics. https://link.springer.com/article/10.1007/s44174-025-00324-2

Vidhya Bhusari | Pharmaceutical Sciences | Women Researcher Award

Published-on by Indian Scientist

Dr. Vidhya Bhusari | Pharmaceutical Sciences | Women Researcher Award

Chitkara College of Pharmacy, Chitkara University, India

Dr. Vidhya Kishore Bhusari is an accomplished pharmaceutical chemist with advanced training in pharmaceutical chemistry and extensive experience spanning academia and the pharmaceutical industry. She has contributed significantly to analytical method development, drug regulatory affairs, and quality assurance. Her research focuses on green analytical chemistry, HPTLC, HPLC, LC-MS techniques, stability-indicating methods, and QbD approaches. She is a recognized award recipient with impactful publications, patents, and scholarly books, contributing meaningfully to pharmaceutical education and research advancement.

Research Metrics (Scopus)

200
150
100
50
10
5
0

Citations
198

Documents
40

h-index
9

Citations

Documents

h-index

Featured Publications

Hardik Kumar | Pharmaceutical Sciences | Best Researcher Award

Published-on by Indian Scientist

Mr. Hardik Kumar | Pharmaceutical Sciences | Best Researcher Award

CT University,  India

Hardik Kumar is a pharmaceutical sciences academic and researcher specializing in pharmacy practice and clinical research. He holds advanced training up to doctoral coursework level, with postgraduate qualifications in pharmacy practice. His experience includes teaching, clinical exposure, pharmacovigilance activities, and academic coordination. His research interests span epilepsy, cardiometabolic disorders, infectious diseases, pharmacotherapy, drug safety, and quality-of-life assessment. He has authored multiple peer-reviewed publications, books, patents, and copyrights, received national-level awards, and actively contributes as a reviewer, speaker, and member of professional scientific bodies.

Citation Metrics (Scopus)

25
20
15
10
5
0

Citations
24

Documents
9

h-index
3

Citations

Documents

h-index

Featured Publications

Srinivasaprabhu Natarajan | Pharmaceutical Management | Research Excellence Award

Published-on by Indian Scientist

Dr. Srinivasaprabhu Natarajan | Pharmaceutical Management | Research Excellence Award

Delvin Formulations | India

An accomplished sales and market expansion professional with strong expertise in B2B strategy, CRM-driven growth, and customer relationship management. Holds advanced academic training in biotechnology and biomedical engineering with a focus on pharmaceutical marketing. Demonstrated experience across leading pharmaceutical organizations, driving territory growth, market penetration, pricing strategy, and sales training initiatives. Research interests include pharmaceutical marketing analytics, CRM optimization, sales forecasting, and market expansion models. Recipient of multiple performance and retention awards, consistently contributing to sustainable business growth and organizational excellence.

Citation Metrics (Scopus)

150
100
50
5
0

Citations
139

h-index
3

Documents
3

Citations

h-index

Documents

Featured Publications


Bio-electrokinetic remediation of crude oil contaminated soil enhanced by bacterial biosurfactant


– Journal of Hazardous Materials · Article · Cited by 93 · 2021


Synthesis of silver nanoparticles from marine bacteria and evaluation of antimicrobial, antifungal and cytotoxic effects


– Journal of King Saud University – Science · Article · Cited by 27 · 2024

All links point to open-access DOI or public repository versions; citation counts may vary across databases.

Pooja Mathur | Pharmaceutics | Excellence in Research Award

Published-on by Indian Scientist

Pooja Mathur | Pharmaceutics | Excellence in Research Award

GD Goenka University | India

Dr. Pooja Mathur is an accomplished academic and researcher in Pharmaceutics with advanced doctoral training and extensive experience in teaching, research, and academic coordination. She has contributed significantly to pharmaceutical sciences through high-impact publications, books, patents, and interdisciplinary research. Her research interests include nanoformulations, drug delivery systems, phytopharmaceuticals, oncology therapeutics, and translational nanomedicine. She actively serves as a reviewer for reputed international journals and has received multiple recognitions for academic excellence, research output, and institutional contributions, reflecting her strong commitment to innovation and scholarly leadership.

Citation Metrics (Scopus)

150
20
10
5
0

Citations
149

Documents
22

h-index
4

Citations

Documents

h-index

Featured Publications

Ashish Sriram Mishra | Pharmaceutics | Research Excellence Award

Published-on by Indian Scientist

Mr. Ashish Sriram Mishra | Pharmaceutics | Research Excellence Award

SRM College of Pharmacy SRMIST Kattankulathur Chennai | India

Mr. Ashish Sriram Mishra is a dedicated researcher in pharmaceutics with strong expertise in novel drug delivery systems, optimization tools, and formulation science, currently pursuing doctoral research at SRM Institute of Science and Technology. He has completed his postgraduate and undergraduate studies in pharmacy with excellent academic performance, building a solid foundation in biopharmaceutics, pharmacokinetics, and advanced pharmaceutical technology. His research focuses on polymeric nanoparticles, lipid-based carriers, targeted gastrointestinal delivery, stability-indicating analytical methods, and drug repurposing strategies. He has authored impactful scientific publications in reputed journals, contributing an h-index of 3, over 40 citations, and more than 10 documents indexed in leading scholarly databases. His work includes advancements in nanomedicine, inflammation management, analytical method development, and Alzheimer’s disease therapeutic strategies. He has hands-on experience in formulation development, characterization techniques, cell studies, microbial assays, instrumental analysis, and design-based optimization, along with proficiency in scientific writing and laboratory documentation. His contributions to pharmaceutics reflect innovation, precision, and a commitment to translational research. He continues to advance his scientific expertise through active research, scholarly publications, and participation in collaborative academic environments, aiming to contribute significantly to pharmaceutical innovation and therapeutic development.

Profile: Google Scholar 

Featured Publications

Mishra, A. S., Vasanthan, M., & Malliappan, S. P. (n.d.). Drug repurposing: A leading strategy for new threats and targets. ACS Pharmacology & Translational Science, 7(4), 915–932.

Mishra, A. S., Sugumaran, A., & Damodharan, N. (n.d.). Nanoparticulate delivery systems for the effective treatment of COPD. Annals of the Romanian Society for Cell Biology, 25(4), 13892–13904.

Mishra, A. S., & Vasanthan, M. (n.d.). Design and validation of a robust stability-indicating reversed-phase HPLC method for quantification of mesalamine in formulated drug products. BMC Chemistry, 19(1), 303.

Mishra, A. S., Vasanthan, M., & Pandey, C. (n.d.). Comparative in silico human and environmental hazard profiling of ulcerative colitis pharmaceuticals. Environmental Chemistry and Ecotoxicology.

Mishra, A. S., & Vasanthan, M. (n.d.). Ecofriendly analytical quality by design aided RP-HPLC method for the estimation of mesalamine: Greenness, blueness and whiteness appraisal. Microchemical Journal, Article